News & Updates

A 75-year-old male nonsmoker was diagnosed with adult-onset asthma at 54 years old in 2004, with blood eosino­phil counts (BEC) rising from 1,500 cells/ μL in 2004 to 1,800 cells/μL in 2006, while serum immunoglobulin E (IgE) remained normal. He tested negative for antineutrophil cytoplasmic antibody (ANCA) and stool ova/cysts. 

The presence of certain autoantibodies in patients with systemic sclerosis (SSc) is predictive of interstitial lung disease (ILD) progression, suggests a Singapore study.

The use of the 2022 ESC/ERC definitions of pulmonary arterial hypertension (PAH) has led to the identification of cirrhosis patients with early-stage portopulmonary hypertension (PoPH), who are at greater risk of death, reports a study.

A study conducted in Germany demonstrates the feasibility of singing-based respiratory training (SBRT) among individuals with post-COVID syndrome (PCS) with respiratory disorders.

In children with obstructive sleep apnea (OSA), upper airway collapsibility and inadequate compensatory activity of the dilator muscles are associated with higher apnea-hypopnea index (AHI), suggests a study.

The use of inhaled ciclesonide provides no additional benefit to vaccinated adults exposed to Omicron variants of SARS-CoV-2 in fast-tracking their recovery from acute symptoms, a study has shown.

Getting a COVID-19 shot prior to or during pregnancy reduces the risks of severe maternal disease outcomes and preterm birth, and this protection remains consistent across different variant periods, according to a study from Canada.

Treatment with the combination of savolitinib plus osimertinib prolongs progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) harbouring EGFR mutation and MET amplification, as shown in the phase III SACHI trial.

The investigational extended-release nalbuphine helps alleviate chronic cough associated with idiopathic pulmonary fibrosis (IPF), as shown in the phase IIb CORAL study.